Literature DB >> 33086386

Thiamine Treatment and Favorable Outcome in an Infant with Biallelic TPK1 Variants.

Matthias Eckenweiler1, Johannes A Mayr2, Sarah Grünert3, Angela Abicht4, Rudolf Korinthenberg1.   

Abstract

Episodic encephalopathy due to mutations in the thiamine pyrophosphokinase 1 (TPK1) gene is a rare autosomal recessive metabolic disorder. Patients reported so far have onset in early childhood of acute encephalopathic episodes, which result in a progressive neurologic dysfunction including ataxia, dystonia, and spasticity. Here, we report the case of an infant with TPK1 deficiency (compound heterozygosity for two previously described pathogenic variants) presenting with two encephalopathic episodes and clinical stabilization under oral thiamine and biotin supplementation. In contrast to other reported cases, our patient showed an almost normal psychomotor development, which might be due to an early diagnosis and subsequent therapy. Thieme. All rights reserved.

Entities:  

Year:  2020        PMID: 33086386     DOI: 10.1055/s-0040-1715631

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  2 in total

1.  Case report of two affected siblings in a family with thiamine metabolism dysfunction syndrome 5: a rare, but treatable neurodegenerative disease.

Authors:  Xiaoyan Li; Zhixin Huang; Yong Chen; Xiaolan Sun; Zhaoshi Yi; Jihua Xie; Xiongying Yu; Hui Chen; Jianmin Zhong
Journal:  BMC Neurol       Date:  2022-09-29       Impact factor: 2.903

Review 2.  Pediatric thiamine deficiency disorders in high-income countries between 2000 and 2020: a clinical reappraisal.

Authors:  Benjamin Rakotoambinina; Laurent Hiffler; Filomena Gomes
Journal:  Ann N Y Acad Sci       Date:  2021-07-26       Impact factor: 6.499

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.